Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Remix Therapeutics in the transaction. Remix Therapeutics announced it closed its $60 million financing led by The Column Group. The...
Remix Therapeutics’ $60 Million Financing
Seattle Children’s Launch of BrainChild Bio
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented BrainChild Bio in the deal. Seattle Children announced the launch of BrainChild Bio to accelerate CAR T-cell therapies for...